Endogenous retroviruses synthesize heterologous chimeric RNAs to reinforce human early embryo development.

Summary

This mechanistic study shows that the endogenous retrovirus MLT2A1 produces diverse chimeric RNAs that expand genome targeting and, via HNRNPU, recruit RNA polymerase II to drive global ZGA transcription. Loss of MLT2A1 impairs embryo development and ZGA, indicating an ERV-driven RNA network is essential for human early embryogenesis.

Key Findings

• Human embryos arrested at the eight-cell ZGA stage showed specific down-regulation of ERV MLT2A1.
• MLT2A1 depletion caused developmental failure and reduced ZGA gene expression.
• MLT2A1 synthesized chimeric transcripts with downstream coding/noncoding sequences, expanding genome targeting and partnering with HNRNPU to recruit RNA polymerase II.
• The MLT2A1 chimeric RNA network synergistically boosted ZGA and early embryogenesis.

Clinical Implications

While preclinical, MLT2A1 activity could serve as a biomarker for embryo competence in IVF and inspire strategies to modulate ERV-driven transcription in embryos at risk of ZGA failure.

Limitations

• Preclinical mechanistic study without direct clinical outcomes or interventional testing.
• Sample size and embryo heterogeneity details were not specified; generalizability requires validation.

Future Directions

Validate MLT2A1-based biomarkers for embryo selection and explore targeted modulation of ERV-driven transcription to rescue ZGA failure in assisted reproduction settings.